Dosage & Administration Drug label Prior authorization Financial assistance

Kaletra

(lopinavir / ritonavir)

lopinavir 100 MG / ritonavir 25 MG Oral Tablet [Kaletra]lopinavir 200 MG / ritonavir 50 MG Oral Tablet [Kaletra]

View 1 more

NO BLACK BOX WARNING

Dosage & administration

Tablets: May be taken with or without food, swallowed whole and not chewed, broken, or crushed.

Oral solution: must be taken with food.

KALETRA oral solution is not recommended for use with polyurethane feeding tubes due to potential incompatibility. Feeding tubes composed of silicone or polyvinyl chloride (PVC) can be used.

Adults :

* Total recommended daily dosage is 800/200 mg given once or twice daily.

* KALETRA can be given as once daily or twice daily regimen. See Full Prescribing Information for details.

* KALETRA once daily dosing regimen is not recommended in:
•Adult patients with three or more of the following lopinavir resistance-associated substitutions: L10F/I/R/V, K20M/N/R, L24I, L33F, M36I, I47V, G48V, I54L/T/V, V82A/C/F/S/T, and I84V.
• In combination with carbamazepine, phenobarbital, or phenytoin.
• In combination with efavirenz, nevirapine, or nelfinavir.
• In pregnant women.

Pediatric Patients (14 days and older) :

* KALETRA once daily dosing regimen is not recommended in pediatric patients.

* Twice daily dose is based on body weight or body surface area.

Concomitant Therapy in Adults and Pediatric Patients:

* Dose adjustments of KALETRA may be needed when co-administering with efavirenz, nevirapine, or nelfinavir.

* KALETRA oral solution should not be administered to neonates before a postmenstrual age (first day of the mother’s last menstrual period to birth plus the time elapsed after birth) of 42 weeks and a postnatal age of at least 14 days has been attained

Pregnancy ( 2.5):

* 400/100 mg twice daily in pregnant patients with no documented lopinavir-associated resistance substitutions.

* There are insufficient data to recommend a KALETRA dose for pregnant patients with any documented KALETRA-associated resistance substitutions.

* No dose adjustment of KALETRA is required for patients during the postpartum period.

drug label

Kaletra prescribing information

Have more Kaletra questions?

Submit MSL Request

Learn More

Need to report a Kaletra issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Kaletra Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

NOT PROVIDED BY BRANDBenefits investigation resources

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Kaletra Financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Rebate Form

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Kaletra Patient education

Getting started on Kaletra

NOT PROVIDED BY BRANDInstructions For Use: Kaletra

Patient toolkit

Patient Resources

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Kaletra FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Kaletra

Dosage & administration

drug label

Kaletra prescribing information

Have more Kaletra questions?

Need to report a Kaletra issue?

prior authorization

Kaletra Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Kaletra Financial assistance options

Co-pay savings program

Bridge program

Foundation programs

patient education

Kaletra Patient education

Getting started on Kaletra

Patient toolkit

people also ask

Kaletra FAQs

Can't find what you're looking for?